Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantGALDERMA SINGAPORE PRIVATE LIMITED
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
SUBCUTANEOUS
Medical Information
D11AH12
Manufacturer Information
GALDERMA SINGAPORE PRIVATE LIMITED
Vetter Pharma-Fertigung GmbH & Co. KG
Active Ingredients
Documents
Package Inserts
Nemluvio Powder and Solvent for Solution for Injection PI.pdf
Approved: March 17, 2025
Patient Information Leaflets
Nemluvio Powder and Solvent for Solution for Injection PIL.pdf
Approved: March 17, 2025